A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 82
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LRP4
Long Form : lipoprotein receptor-related protein 4
No. Year Title Co-occurring Abbreviation
2021 Ablation of Lrp4 in Schwann Cells Promotes Peripheral Nerve Regeneration in Mice. AChRs, cKO, NMJ
2021 Amyloid β Clearance Is Disrupted by Depletion of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytes. ---
2021 Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. AChRs, MG, MuSK
2021 Secreted Signaling Molecules at the Neuromuscular Junction in Physiology and Pathology. AChRs, CMS, CTGF, FGF, MuSK, NMJ
2021 The extracellular matrix protein Agrin is expressed by osteoblasts and contributes to their differentiation. BMP, Wnt
2021 Timing and localization of myasthenia gravis-related gene expression. AChR, CNS, MG, MuSK
2020 A novel biallelic splice-site variant in the LRP4 gene causes sclerosteosis 2. CLSS, SOST2
2020 A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance. AD
2020 AChRs Degeneration at NMJ in Aging-Associated Sarcopenia-A Systematic Review. ACh, AChRs, MRFs, NMJ
10  2020 Anti-LRP4 Antibody-associated Myasthenia Gravis with a Rare Complication of Thymoma Successfully Treated by Thymectomy. MG
11  2020 Antigen specific B cells in myasthenia gravis patients. AChR, MG, MuSK
12  2020 Autoantibodies in Japanese patients with ocular myasthenia gravis. Abs, AChR, CBAs, MG, MuSK, OMG
13  2020 Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. AChR, MG, MuSK
14  2020 Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology. AChR, CIDP, FAE, MG, MuSK, NMJ, NMO, PV
15  2020 Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study. DNMG, MG, MGFA
16  2020 Dissecting the Extracellular Complexity of Neuromuscular Junction Organizers. MuSK, NMJ
17  2020 LRP4 LDLα repeats of astrocyte enhance dendrite arborization of the neuron. CNS, ECD, NMJ
18  2020 LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p. EMT, GC
19  2020 Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment. AChR, MuSK-MG, NMJ
20  2020 Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management. CBAs, MG, RIPA
21  2020 Neuronal MT1-MMP mediates ECM clearance and Lrp4 cleavage for agrin deposition and signaling in presynaptic development. ECM, MT1-MMP, NMJs
22  2019 Agrin-Lrp4-Ror2 signaling regulates adult hippocampal neurogenesis in mice. EE, NSPCs, ROR2
23  2019 Alternative Splicing and the Intracellular Domain Mediate TM-agrin's Ability to Differentially Regulate the Density of Excitatory and Inhibitory Synapse-like Specializations in Developing CNS Neurons. CNS, MuSK, TM-agrin
24  2019 Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism. ---
25  2019 Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture. AChR, MG, MuSK, NMJ
26  2019 Pathogenic effects of agrin V1727F mutation are isoform specific and decrease its expression and affinity for HSPGs and LRP4. NMJ
27  2019 Sclerostin/Receptor Related Protein 4 and Ginkgo Biloba Extract Alleviates beta-Glycerophosphate-Induced Vascular Smooth Muscle Cell Calcification By Inhibiting Wnt/beta-Catenin Pathway. beta-GP, BGP, CKD, GBE, VSMC
28  2018 A 5-Year Follow-Up of Triple-Seronegative Myasthenia Gravis Successfully Treated with Tacrolimus Therapy. AChR, MG, MuSK
29  2018 Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Double Seronegative Myasthenia Gravis: A Systematic Review. MG
30  2018 Characterization of the thymus in Lrp4 myasthenia gravis: Four cases. AChR, EOMG, MG
31  2018 Deficiency of lrp4 in zebrafish and human LRP4 mutation induce aberrant activation of Jagged-Notch signaling in fin and limb development. CLS
32  2018 Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice. AChR, M-agrin, MG, MuSK, N-agrin, NMJ
33  2018 Late-onset Myasthenia Gravis Accompanied by Amyotrophic Lateral Sclerosis with Antibodies against the Acetylcholine Receptor and Low-density Lipoprotein Receptor-related Protein 4. AChR, ALS, MG
34  2018 Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence. AChR, MG, MuSK
35  2018 Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features. AChR, CBA, MG, MuSK, RIPA
36  2018 Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes. MG, MuSK
37  2018 Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review. AD, AR, SOST
38  2018 [Myasthenia gravis: current status of antibody diagnostics and aspects on refractory myasthenia gravis]. AChR, MG, MuSK
39  2017 Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma. AChR, MG
40  2017 Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis. Abs, MG, MuSK
41  2017 Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice. AChR, EAMG, MG, MuSK, NMJ
42  2017 Low-Density Lipoprotein Receptor-Related Protein 4-Positive Myasthenia Gravis in a Double-Seronegative, Electromyography-Negative Patient. ---
43  2017 Multiple antibody detection in 'seronegative' myasthenia gravis patients. AChR, MG, MuSK, SNMG
44  2017 Neuronal LRP4 regulates synapse formation in the developing CNS. ---
45  2016 Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort. Abs, AChR, CBA, MuSK, RIA
46  2016 Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin. AChR, dSNMG, MG, MuSK
47  2016 Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. AChR, MG, MuSK
48  2016 Double Seronegative Myasthenia Gravis with Anti-LRP4 Antibodies Presenting with Dropped Head and Acute Respiratory Insufficiency. AChR, MG, MuSK
49  2016 Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis. AChR, MG, MuSK, RNS
50  2016 Lrp4 in astrocytes modulates glutamatergic transmission. ---
51  2016 Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports. ALS, MG, NMJ
52  2016 Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms. AChR, Ig, MuSK, NMJ
53  2016 R-spondin 2 promotes acetylcholine receptor clustering at the neuromuscular junction via Lgr5. AChR, Lgr5, MuSK, NMJ, RSPO2, SMN
54  2016 Roles of collagen Q in MuSK antibody-positive myasthenia gravis. AChE, AChR, ColQ, MG, MuSK, NMJ
55  2015 Agrin mediates chondrocyte homeostasis and requires both LRP4 and α-dystroglycan to enhance cartilage formation in vitro and in vivo. ECM, OA
56  2015 Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis. AChR, CBAs, MG, RIPA, SNMG
57  2015 Collagen Q--a potential target for autoantibodies in myasthenia gravis. AChE, AChR, CBA, ColQ, MG, MuSK, NMJ, SNMG
58  2015 Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis. AChR, dSN, MG, MuSK
59  2015 Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia. CMS, EPP, EPs, MuSK
60  2015 LRP4 in neuromuscular junction and bone development and diseases. LDLR
61  2014 A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. CBA
62  2014 Anti-agrin autoantibodies in myasthenia gravis. AChR, MG, MuSK
63  2014 LRP4 induces extracellular matrix productions and facilitates chondrocyte differentiation. ACAN
64  2014 Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice. AChR, CFA, EAMG, Ig, MG, MuSK
65  2014 Rapid skeletal turnover in a radiographic mimic of osteopetrosis. BMD, OPG, OPT, SOST
66  2014 [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis]. Abs, AChR, MG, MuSK
67  2013 Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. AChR, CMAPs, MG, NMJ
68  2013 Cenani-Lenz syndrome restricted to limb and kidney anomalies associated with a novel LRP4 missense mutation. CLS
69  2013 Mesdc2 plays a key role in cell-surface expression of Lrp4 and postsynaptic specialization in myotubes. NMJ
70  2013 MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. MG, MuSK
71  2013 MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters. AChRs, MG, MuSK
72  2013 Myasthenia gravis: an update for the clinician. MG, MuSK
73  2013 Proteomic profiles reveal age-related changes in coelomic fluid of sea urchin species with different life spans. ---
74  2013 The search for new antigenic targets in myasthenia gravis. ---
75  2013 [Autoantibodies in myasthenia gravis]. Abs, GLIP, MG, NMJ
76  2013 [Novel autoantibodies in myasthenia gravis]. Abs, ColQ, Kv1.4, MG, MuSK
77  2012 Autoimmune mechanisms in myasthenia gravis. AChR
78  2012 [Progress of myasthenia gravis: discovery of Lrp4 antibodies]. Abs, AChR, MG, MuSK
79  2007 A role for LRP4 in neuronal cell viability is related to apoE-binding. APOE
80  2007 Congenital syndactyly in cattle: four novel mutations in the low density lipoprotein receptor-related protein 4 gene (LRP4). ---
81  2006 Expression of low density lipoprotein receptor-related protein 4 (Lrp4) gene in the mouse germ cells. PGCs
82  2006 LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. NMJ